Kevin Land/LinkedIn
Apr 14, 2026, 09:09
Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
Kevin Land, Interim Laboratory and Medical Director Adult HSC Lab at UPMC Hillman Cancer Center, shared a post on LinkedIn։
“How cool is this clinical impact?
Deep normalization of hemoglobin with near‑elimination of vaso‑occlusive events in most treated patients, achieved by directly reactivating fetal hemoglobin at the γ‑globin promoters.
Compared with standard sickle cell care, often with multiple vaso-occlusive crises a year per patient, this represents a step‑change, from disease mitigation and symptomatic care to functional correction.
Early data suggests durable benefit driven by stable stem‑cell editing.”
Stay updated with Hemostasis Today.
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA
-
May 29, 2026, 16:46Soumen Bhattacharya: UC-II and Immune Modulation in Osteoarthritis
-
May 29, 2026, 16:38Ana Pedrero Gil: Red Blood Cell Transfusion Practice in Spain – High Inappropriateness Despite Low Overall Use
-
May 29, 2026, 15:40Lena Volland: Expanding Holistic Care in Bleeding Disorders Through Pelvic Health Physical Therapy at WFH Congress